BioPharma
03 July, 2026 | Friday | Analysis
Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
THE GATE The choke point nobody puts on the slide Somewhere in the region this quarter, a cell-and-gene developer has everything the pitch deck promised. The Phase I data is clean. Patients are enrolled. A re...
Lab
01 July, 2026 | Wednesday | News
Colossal Foundation and University of Tasmania Partner to Fight Deadly Tasmanian Devil Cancer with Gene Editing and Vaccines
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmani...
BioTech
08 July, 2026 | Wednesday | Analysis
After the Rush: APAC's mRNA and Vaccine Capacity Hangover
In June 2022, South Korea had something it had wanted for two years: a COVID-19 vaccine of its own. SKYCovione, developed by SK bioscience with the University of Washington's Institute for Protein Design ...
Contract Services
08 July, 2026 | Wednesday | News
Matica Bio Partners with VaxDome to Advance Novel Intranasal Antiviral Vaccine Platform into Clinical Trials
Matica Biotechnology, Inc. ("Matica Bio"), a viral vector contract development and manufacturing organization (CDMO), is partnering with Texas-based biotech VaxDome Inc. to bring its novel antigen-agnostic anti...
Consumer Health
02 July, 2026 | Thursday | News
ALR Technologies Expands Diabetes Device Business with CGM Medical Acquisition
ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical Technology Singapo...
Medtech
08 July, 2026 | Wednesday | News
World's First International Patient Begins Satri-cel Treatment at Jiahui International Cancer Center
Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a historic m...
Cell & Gene
08 July, 2026 | Wednesday | News
World's First International Patient Begins Satri-cel Treatment at Jiahui International Cancer Center
Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a historic m...
White Paper
08 July, 2026 | Wednesday | Analysis
After the Rush: APAC's mRNA and Vaccine Capacity Hangover
Product Spot Light
26 June, 2026 | Friday | News
Waters and IMU Biosciences Partner to Advance AI-Powered High-Definition Immune Profiling
Premium Article
08 July, 2026 | Wednesday | Analysis
APAC's Peptide-Capacity Gamble
Bio Invest
06 July, 2026 | Monday | News
Vitex Inaugurates A$250M Wonderland Manufacturing Hub in Western Sydney
Biopharma APAC Infomercial
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
